Control of the antitumoral activity of human macrophages produced in large amounts in view of adoptive transfer
- 1 November 1988
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 24 (11) , 1691-1698
- https://doi.org/10.1016/0277-5379(88)90069-7
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- Activation of cytotoxic activity in cultures of bone marrow‐derived macrophages by indomethacinEuropean Journal of Immunology, 1987
- Formation and metabolism of leukotriene C4 in macrophages exposed to bacterial lipopolysaccharideEuropean Journal of Biochemistry, 1986
- Treatment of Advanced Non-Hodgkin's Lymphoma with Recombinant Leukocyte a InterferonNew England Journal of Medicine, 1984
- Primary cultures of human blood-born macrophages grown on hydrophobic teflon membranesJournal of Immunological Methods, 1983
- Interferon‐induced enhancement of macrophage‐mediated tumor cytolysis and its difference from activation by lymphokinesEuropean Journal of Immunology, 1981
- Fractionation, morphological and functional characterization of effector cells responsible for human natural killer activity against cell-line targetsCellular Immunology, 1979
- Natural Killer Cells: Characteristics and Regulation of ActivityImmunological Reviews, 1979
- Establishment and characterization of a human histiocytic lymphoma cell line (U‐937)International Journal of Cancer, 1976
- Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivativesBiochemical and Biophysical Research Communications, 1974